Bacterial meningitis is a severe and potentially life-threatening infection characterized by inflammation of the membranes surrounding the brain and spinal cord. This condition is primarily caused by bacteria entering the bloodstream and subsequently reaching the central nervous system. Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae are common bacterial culprits responsible for meningitis. The infection typically presents with symptoms such as severe headaches, neck stiffness, fever, and photophobia. Infants may display irritability, poor feeding, and a bulging fontanelle. Rapid diagnosis through cerebrospinal fluid analysis is crucial for effective treatment. Treatment for bacterial meningitis often involves prompt administration of intravenous antibiotics to eliminate the causative bacteria. In some cases, corticosteroids may be prescribed to reduce inflammation and minimize complications. Early intervention is essential, as delayed treatment can lead to severe neurological consequences and, in some instances, death. Prevention strategies include vaccinations against specific bacterial strains that commonly cause meningitis, such as the meningococcal and pneumococcal vaccines. Public health measures, such as maintaining good hygiene practices, also play a role in reducing the risk of bacterial meningitis transmission.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation